XJH Performance — iShares ESG Select Screened S&P Mid-Cap ETF
Data updated: 2026-08-27
XJH returned +17.37% year to date and +26.96% over one year to Jun 2026. Annualised returns are +15.04% over 3 years and +8.50% over 5 years. Against its Thematic Equity category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $152, against $161 for the category, and to $127 over one year, against $115. Volatility over the past three years was 16.42% a year. In the 12 months to Jun 2026 the fund took in a net $56.2M, and assets reached $419.47M.
XJH Growth of $100
What $100 invested in iShares ESG Select Screened S&P Mid-Cap ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Thematic Equity category average over the same months.
| Period | XJH | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $127 | $115 |
| 3 years (Jul 2023 – Jun 2026) | $152 | $161 |
| 5 years (Jul 2021 – Jun 2026) | $150 | $141 |
| Since data start (Sep 2020 – Jun 2026) | $223 | $186 |
XJH Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +17.37% |
| 1 year | +26.96% |
| 3 years (annualised) | +15.04% |
| 5 years (annualised) | +8.50% |
XJH Annual Returns
Calendar-year total returns of iShares ESG Select Screened S&P Mid-Cap ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +17.37% |
| 2025 | +8.07% |
| 2024 | +12.23% |
| 2023 | +16.82% |
| 2022 | −14.32% |
| 2021 | +23.54% |
| 2020 (Sep–Dec) | +26.60% |
XJH Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.0% | +4.0% | −5.9% | +8.0% | +2.8% | +3.8% | — | — | — | — | — | — |
| 2025 | +3.8% | −4.3% | −5.8% | −2.1% | +5.4% | +3.4% | +1.5% | +3.8% | +0.4% | −0.5% | +2.5% | +0.4% |
| 2024 | −1.7% | +5.4% | +5.4% | −6.5% | +4.6% | −1.4% | +6.0% | −0.2% | +1.4% | −1.2% | +8.8% | −7.5% |
| 2023 | +9.6% | −1.6% | −3.4% | −0.9% | −3.1% | +9.3% | +4.1% | −2.9% | −5.5% | −5.9% | +9.0% | +9.2% |
| 2022 | −7.3% | +0.8% | +0.9% | −7.5% | +0.3% | −9.3% | +10.8% | −3.6% | −8.7% | +10.3% | +6.2% | −5.5% |
| 2021 | +1.5% | +6.9% | +4.4% | +4.7% | 0.0% | −1.1% | +0.4% | +1.7% | −4.3% | +5.7% | −2.7% | +4.9% |
| 2020 | — | — | — | — | — | — | — | — | +1.8% | +2.1% | +14.3% | +6.6% |
XJH Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 16.42%
- 3-year Sharpe ratio: 0.64 (vs 4.5% risk-free rate)
- Best month: +9.25% (Dec 2023)
- Worst month: −7.51% (Dec 2024)
XJH Fund Flows
Monthly money in and out of iShares ESG Select Screened S&P Mid-Cap ETF, from SEC Form N-PORT.
- 12-month net flow: $56.2M
- 12-month gross sales (incl. reinvestments): $104.2M
- Sales ÷ redemptions: 2.17×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $15.3M | $5.1M | $10.2M |
| May 2026 | $12.3M | $0 | $12.3M |
| Apr 2026 | $4.7M | $6.9M | −$2.2M |
| Mar 2026 | $20.5M | $17.9M | $2.6M |
| Feb 2026 | $7.2M | $4.7M | $2.5M |
| Jan 2026 | $2.3M | $0 | $2.3M |
| Dec 2025 | $11.2M | $6.8M | $4.4M |
| Nov 2025 | $4.3M | $0 | $4.3M |
| Oct 2025 | $4.4M | $0 | $4.4M |
| Sep 2025 | $15.5M | $4.4M | $11.1M |
| Aug 2025 | $2.2M | $0 | $2.2M |
| Jul 2025 | $4.2M | $2.1M | $2.1M |
XJH Assets Under Management
Net assets of iShares ESG Select Screened S&P Mid-Cap ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $419.47M |
| 2026-03-31 | $346.61M |
| 2025-12-31 | $334.49M |
| 2025-09-30 | $315.21M |
| 2025-06-30 | $284.56M |
| 2025-03-31 | $255.54M |
| 2024-12-31 | $246.66M |
| 2024-09-30 | $236.63M |
| 2024-06-30 | $199.56M |
| 2024-03-31 | $180.76M |
| 2023-12-31 | $137.64M |
| 2023-09-30 | $111.60M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.